Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects

Journal of Ethnopharmacology

Volumn 117, Issue 3, 2008, Pages 491-495

  Prasongwatana, Vitoon ^a   Woottisin, Surachet ^a   Sriboonlue, Pote ^a   Kukongviriyapan, Veerapol ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Hibiscus sabdariffa; Renal stone; Roselle callyces; Uric acid; Urinary fractional excretion

Indexed keywords

CALCIUM; CITRIC ACID; GLYCOLIC ACID; HIBISCUS SABDARIFFA EXTRACT; MAGNESIUM; OXALIC ACID; POTASSIUM; SODIUM; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; NEPHROLITHIASIS; RISK FACTOR; TEA; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; BEVERAGES; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; FEMALE; HIBISCUS; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; RISK FACTORS; URIC ACID; URICOSURIC AGENTS;

HIBISCUS SABDARIFFA;

EID: 42749092402     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.02.036     Document Type: Article

References (29)

1. Ajay M., Chai H.J., Mustafa A.M., Gilani A.H., and Mustafa M.R. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. Journal of Ethnopharmacology 109 (2007) 388-393
2. Ali M.B., Salih W.M., Mohamed A.H., and Homeida A.M. Investigation of the antispasmodic potential of Hibiscus sabdariffa calyces. Journal of Ethnopharmacology 31 (1991) 249-257
3. Atmani F., Slimani Y., Mimouni M., Aziz M., Hacht B., and Ziyyat A. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats. Journal of Ethnopharmacology 95 (2004) 87-93
4. Chewonarin T., Kinouchi T., Kataoka K., Arimochi H., Kowahara T., Vinittutkumneun U., and Ohniahi Y. Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats. Food and Chemical Toxicology 37 (1999) 591-601
5. El-Saadany S.S., Sitohy M.Z., Labib S.M., and El-Massry R.A. Biochemical dynamic and hypocholesterolemic action of Hibiscus sabdariffa L. (Karkada). Die Nahrung 35 (1991) 567-576
6. Ettinger B. Does hyper-uricosuria play a role in calcium oxalate lithiasis?. Journal of Urology 141 (1989) 738-741
7. Farnworth N.R., and Bunyapraphatsara N. Thai Medicinal Plants (1992), Prachachon Press, Bangkok pp. 163-166
8. Freitas A.M., Schor N., and Boim M.A. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. British Journal of Urology International 89 (2002) 829-834
9. Gutman A.B. Uricosuric drugs, with special reference to probenecid and sulfinpyrazone. Advances in Pharmacology 4 (1966) 91-142
10. Haji-Faraji M., and Haji-Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. Journal of Ethnopharmacology 65 (1999) 231-236
11. Herrera-Arellano A., Flores-Romero S., Chavez-Soto M.A., and Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine 11 (2004) 375-382
12. Herrera-Arellano A., Miranda-Sanchez J., Avila-Castro P., Herrera-Alvarez S., Jimenez-Ferrer J.E., Zamilpa A., Roman-Ramos R., Ponce-Monter H., and Tortoriello J. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Medica 73 (2007) 6-12
13. Hirunpanich V., Utaipat A., Morales N.P., Bunyapraphatsara N., Sato H., Herunsalee A., and Suthisisang C. Antioxidant effects of aqueous extracts from dried calyx of Hibiscus sabdariffa Linn. (roselle) in vitro using rat low-density lipoprotein (LDL). Biological Pharmaceutical Bulletin 28 (2005) 481-484
14. Hirunpanich V., Utaipat A., Molales N.P., Bunyapraphatsala N., Sato H., Herunsale A., and Suthisisang C. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats. Journal of Ethnopharmacology 103 (2006) 252-260
15. Holmes R.P. Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance. Clinical Chemistry 41 (1995) 1297-1301
16. Kippen I., Whitehouse M.W., and Klinenberg J.R. Pharmacology of uricosuric drugs. Annals of the Rheumatic Diseases 33 (1974) 391-396
17. Kirdpon S., Na Nakorn S., and Kirdpon W. Changes in urinary chemical composition in healthy volunteers after consuming roselle (Hibiscus sabdariffa Linn.) juice. Journal of Medical Association of Thailand 77 (1994) 314-321
18. Klinenberg J.R. The effectiveness of allopurinol in the treatment of gout. Arthritis Rheumatism 8 (1965) 891-895
19. Krissanapan V. Interesting Thai Herbal Plants. 2nd ed. (1996), Chulalongkorn University Press [In Thai], Bangkok
20. Muanwongyathi P. Thai Herbal Teas. 3rd ed. (1996), Medical Media [In Thai], Bangkok
21. Nirdnoy M., and Muangman V. Effects of Folia orthosiphonis on urinary stone promoters and inhibitors. Journal of Medical Association of Thailand 74 (1991) 318-321
22. Panutas K. Thai Herbal Plants; Anti-diabetes Mellitus, Anti-hemorrhoid and Diuretic (2001), Rungsang Publishing [In Thai], Bangkok
23. Petrarulo M., Facchini P., Cerelli E., Marangella M., and Linari F. Citrate in urine determined with a new citrate lyase method. Clinical Chemistry 41 (1995) 1518-1521
24. Premgamone A., Reungjui S., Jaipakdee S., Prasongwatana J., Suwuntrai S., Maskasem S., and Sriboonlue P. The effects of Orthosiphon grandiflorus on risk factors of renal stone disease. Thai Journal of Urology 23 (2002) 57-70
25. Selvam R., Kalaiselvi P., Govindaraj A., Bala Murugan V., and Sathish Kumar A.S. Effect of Aerva lanata L. leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacological Research 43 (2001) 89-93
26. Scott J.T., Hall A.P., and Grahame R. Allopurinol in treatment of gout. British Medical Journal 2 (1966) 321-327
27. Smith S.T. Non-protein nitrogen. In: Fody E.P. (Ed). Clinical Chemistry; Principles, Procedures, Correlations. 2nd ed. (1992), J.B. Lippincott Company, Philadelphia 435-452
28. Toffaletti J.G., and Jones P.J. Electrolytes. In: Bishop M.L., Duben-Engelkirk J.L., and Fody E.P. (Eds). Clinical Chemistry; Principles, Procedures, Correlations (1992), J.B. Lippincott Company, Philadelphia 269-294
29. Yasui T., Fujita K., Sato M., Sugimoto M., Iguchi M., Nomura S., and Kohri K. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urological Research 27 (1999) 194-199